1. Home
  2. ALUR

as 05-20-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Founded: 2009 Country:
United States
United States
Employees: 24 City: NATICK
Market Cap: 84.9M IPO Year: N/A
Target Price: $5.00 AVG Volume (30 days): 1.0M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.70 EPS Growth: N/A
52 Week Low/High: $1.56 - $10.94 Next Earning Date: 05-14-2024
Revenue: $48,781,000 Revenue Growth: -25.60%
Revenue Growth (this year): 18.37% Revenue Growth (next year): 25.46%

Share on Social Networks: